|
HS Code |
266069 |
| Chemical Name | Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate |
| Cas Number | 88149-49-9 |
| Molecular Formula | C9H6BrF3O2 |
| Molecular Weight | 283.04 |
| Appearance | White to off-white solid |
| Melting Point | 47-51°C |
| Purity | Typically ≥98% |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Smiles | COC(=O)C1=CC(=C(C=C1)Br)C(F)(F)F |
| Inchi | InChI=1S/C9H6BrF3O2/c1-15-9(14)5-2-3-7(10)8(4-5)6(11,12)13/h2-4H,1H3 |
| Density | 1.65 g/cm3 |
| Refractive Index | 1.525 (predicted) |
| Synonyms | Methyl 4-bromo-3-(trifluoromethyl)benzoate |
As an accredited Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Talking about specialty chemicals like Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate takes me back to countless lab sessions where tiny tweaks in molecular structure opened new doors on the synthesis front. In research circles, this compound isn’t just another tube on the shelf — it’s the quiet backbone in many organic syntheses, helping chemists nudge molecules in directions not possible just a few decades ago. Behind the long name is a molecule with a sharp mix of reactivity and selectivity, something you rarely find in simpler aromatic esters.
A lot of folks overlook how minor changes in a benzene ring can play out across reactions down the line. Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate brings two unique features together: a bromine atom sitting on the 4-position and a trifluoromethyl group on the 3-position. In chemical terms, those mean this molecule pulls its weight in cross-coupling and other tough reactions, holding up under a variety of conditions that might throw similar molecules off track. The methyl ester itself keeps the functionality easy to transform, without bogging the process down with extra steps.
From my time in the lab, going after custom pharmaceuticals often means running a handful of Suzuki or Stille couplings. The bromo group here is more than a placeholder—it puts this compound front and center on the reaction roadmap. The trifluoromethyl group doesn’t lag behind; it can shift things by affecting electron density and, ultimately, the selectivity of each reaction. Compared to anything with less halogenation or no strong electron-withdrawing groups, the difference in reactivity becomes obvious, especially after a few pilot runs.
Synthetic chemists tend to look for clarity in performance. This compound’s structure gives just that: a single bromo on the benzene ring, three fluorines right where you want them, and the ester group waiting for downstream changeups. Its formula—C9H6BrF3O2—packs all the usual elements without excess, which makes for reliable handling and pretty straightforward purification steps. Clean melting, distinct NMR signals, and a stability window let research continue with fewer setbacks.
In the pharmaceutical world, every gram counts. Fewer side reactions mean more yield and better consistency from batch to batch. I’ve seen labs save whole weeks on single-route syntheses just by swapping in Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate for a less active benzoate derivative. In a research setting running tight budgets and tighter timelines, that edge is real.
Adding a trifluoromethyl group anywhere in a molecule tends to do more than just add weight. It screws with polarity, changes how solvent interacts, and makes drug discovery teams sit up and reconsider old reaction charts. It isn’t often that a single change pulls up activity in both the chemical and biological sense, but that’s exactly what fluorinated groups are famous for. The electron-withdrawing punch from the three fluorines on this compound can make new reaction pathways not only feasible but efficient.
You see this play out in medicinal chemistry, where tweaking a lead candidate with a trifluoromethyl pattern can pump up membrane permeability and metabolic resilience. Take two benzoates—one with a simple methyl and another with trifluoromethyl—test them across the usual transformations, and the differences pop out under HPLC analysis. More than a few promising drug scaffolds have started from experiments right here.
Labs test a lot of starting materials that look close on paper but act surprisingly different on the bench. Regular methyl 4-bromobenzoate, for example, works fine in basic couplings, but it doesn’t have the same punch as the trifluoromethyl version. The trifluoromethyl group doesn’t just change reactivity; it can drop a whole raft of potential side products by dialing down sites vulnerable to oxidation or rearrangement.
I remember running parallel synthesis with several brominated esters. Those with extra electron-donating groups ended up with runaway byproducts after each cross-coupling. The trifluoromethyl variant pushed better yields and fewer headaches during column work. It stands out any time you want selective functionalization without dragging in instability or loss of starting material.
Many chemists seeking greener protocols also turn to this compound as an alternative to more hazardous halides, especially those that introduce problematic waste streams. The presence of both bromine and trifluoromethyl on a single aromatic ring offers strong activation for palladium-catalyzed couplings while keeping toxicological profiles more manageable than, say, iodinated analogues.
It’s easy to see a compound like this as a niche research tool, but the applications reach far past the average reaction flask. In pharmaceutical research, the search for molecules with improved absorption, distribution, metabolism, and elimination starts with frameworks that resist early breakdown. Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate steps up in early lead diversification, letting med-chem teams try out new aryl-linked fragments and test SAR hypotheses.
Agrochemistry has seen similar gains, especially in the hunt for active ingredients that can hang tough through weather swings and exposure. Building new herbicides or fungicides on platforms that incorporate trifluoromethylbenzoate patterns brings down degradation rates and supports lower field dosing. My colleagues in crop science mention this class of intermediates as central to hitting both yield and safety targets.
Even in materials chemistry, those chasing new polymers or OLED components look hard at the effect of halogenation and fluorination. The consistency achieved from Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate streams straight into process development for specialty coatings and next-gen plastics. The stable backbone and fine-tuned electronics mean less stumbling on the way to scalable new products.
Anyone who’s spent time with aromatic esters knows the usual storage headaches. With this molecule, stability shows up right away — resistance to ambient light, non-hygroscopic behavior, and a distinct lack of sticky residue even after weeks in a regular storage cabinet. It easily powders down for accurate weighing, and the crystalline nature means splits between research teams run without the fuss of sticky glassware.
Solubility also stands out. You get decent mixing in standard organic solvents without resorting to more hazardous or high-boiling mixtures. This matters for both small-scale synthesis and early formulation work, where every extra solvent swap costs more than a little lab time.
I’ve lost count of the projects derailed by inconsistent reagent quality. One bad batch can throw off whole screening campaigns or torpedo scale-up runs. Quality sourcing for Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate means more than purity percentage—it’s about batch tracking, reproducible crystallinity, and tight control on related impurities. Labs that chase innovative chemistries often rely on multi-step sequences, so researchers double-check consistency with each new order, running side-by-side reactions to head off surprises.
GC and NMR data give the first clues here: sharp single peaks, well-resolved splitting, and a lack of persistent unknowns. Top outlets ship with independent certificates, traceable batches, and user-driven quality checks. This makes more difference than any lip-service to “high purity,” especially with high-stakes patent filings or regulatory submissions.
People ask tough questions about environmental safety, and rightfully so. The trifluoromethyl group, for all its utility, draws scrutiny over persistence and fluorine-related toxicity. Most modern suppliers aim for low-waste production, recovering as much reagent as possible and minimizing venting. Batch synthesis in the right hands can drop process waste below legacy halogenation methods, and teams pushing for greener chemistry keep this under a microscope.
On the user’s end, following the best practices for storage, handling, and disposal isn’t just bureaucracy — it protects both workspaces and the local ecosystem. Researchers turn to published MSDS materials and seek ongoing updates, not just for personal safety, but to pass audits and maintain accreditation. In highly regulated industries, tighter tracking of reagent history plays into sustainability ratings and overall facility compliance.
Few things matter more to me than seeing a basic chemical unlock fresh invention. Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate, with its blend of reactivity and flexibility, gives a reliable launch point for chemists looking to try new routes and test new ideas. Its unique structure catches the eye of those running combinatorial libraries or building up core scaffolds for next-gen treatments, whether small molecule or more complex macrocycles.
Patent filings often hinge on unique building blocks. Those who underestimate the value of this compound may miss out on defensive patent positions, since its substitution pattern offers paths less traveled compared to simpler benzene derivatives. Having worked closely with IP teams, I’ve seen the strategic value in including halogen- and fluorine-substituted aromatics, hedging bets as projects move through preclinical to early clinical phases.
Lab-scale success counts for little if it can’t transition upwards. Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate has proven scale-up credentials. Reaction reliability and manageable purification translate straight from milligram to multi-kilo quantities. Process chemists working at the interface between bench and plant scale see fewer surprises due to thermal properties and non-hygroscopic form, avoiding common pitfalls that sideline less robust intermediates.
Cost always figures in. Entry-level investment into early-stage synthesis makes sense if the route stands up under scrutiny. Supply chain stability grows more important every year, as global labs now coordinate multi-country projects that depend on timely and consistent reagent availability. This compound delivers on that front, with most requests filled from established and audited supply networks.
Standing alongside traditional benzoate esters or other brominated aromatics, Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate almost always offers cleaner handling, less decomposition risk, and more reliable process flow. The extra cost isn’t always negligible, but in head-to-head trials, labs often come away favoring it for performance gains alone. I remember the switch from simple 4-bromo derivatives to this compound in a startup’s focus project, which bumped up target conversion rates and left less clean-up at the backend.
Process hazards also tilt in its favor. Without the volatility or environmental risk associated with heavier brominated compounds, and while steering clear of problematic iodinated materials, this molecule walks a straight line between operational safety and strong reactivity. Labs aiming for competitive new routes to APIs and specialty chemicals increasingly mark this as a go-to solution.
Like every specialty chemical, use cases bring challenges. Some routes targeting Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate run into solubility limits, which, based on past experience, can be tackled by selecting from a wider range of organic solvents or optimizing reaction temperature. Product sensitivity in downstream transformations occasionally appears, but thoughtful reagent choices and stepwise adjustment of reaction parameters keep most projects on track.
For researchers worried about long-term supply chain reliability, building relationships with multiple suppliers and running small-scale validation tests on arrival remain smart moves. On sustainability, the industry moves towards continuous-flow setups and greener catalysts, both of which reduce waste and offer better control over emissions. My own shift to laboratory recycling programs, even if it started out of regulatory necessity, grew into a core part of how we designed experimental protocols.
There’s a certain satisfaction in seeing once-uncommon reagents like Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate become standards in synthetic labs. The compound doesn’t just facilitate novel research—it helps laboratories hit targets with more confidence, from synthetic strategy to industrial roll-out. Having worked across academic and industrial sectors, I see teams that place trust in reliable intermediates consistently meet development milestones, often breaking through into new kinds of compounds and applications.
Labs continuously push forward, demanding more control over their reaction outcomes and faster times to result. By bringing together bromine and trifluoromethyl on a stable benzoate platform, this intermediate removes hurdles common to less-designed starting materials. That edge carries through every step, from custom ligand development to complex molecular assemblies.
Chemists balancing innovation and regulatory demands find this compound reduces compromise. Teams can access new chemical space, tune molecular properties, and abide by tighter process controls — all with a building block recognized across major research and manufacturing centers. The chance to combine performance with consistent supply puts Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate in a category few rivals reach.
The world’s appetite for new pharmaceuticals and advanced materials keeps pushing the envelope of chemical synthesis. Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate continues to earn its place in the modern toolkit, thanks to a balance of reactivity, robustness, and regulatory adaptability. As research pivots quickly from idea to reality, I see compounds like this one anchoring both the exploratory and applied sides of the business.
From a chemist’s point of view, the appeal lies in opening new synthesis routes while holding tight to reliability. Infrastructure shifts, automation, and field expansion all lean on intermediates that prove their worth in real-world experiments. This particular benzoate remains central to that progress, reflecting the twin demands for speed and scientific rigor in everything from disease-fighting drugs to groundbreaking new materials.
Perhaps the best endorsement comes from seeing how researchers keep coming back to this intermediate, not out of habit, but because fewer stumbling blocks mean more room for discovery and innovation. Methyl 4-Bromo-3-(Trifluoromethyl)Benzoate stands as a fine example of a chemical that delivers usefulness, safety, and scalability—a rare combination that continues to shape the pace of progress in the lab and beyond.